Skip to content

Clinical Study on the Treatment of Severe Mycoplasma Pneumonia in Children with Yindai Tang Combined with Collapse Stain Therapy

Clinical Study on the Treatment of Severe Mycoplasma Pneumonia in Children with Yindai Tang Combined with Collapse Stain Therapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000073
Enrollment
Unknown
Registered
2024-05-22
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Mycoplasma pneumoniae pneumonia in children

Interventions

Control group:Conventional Western Medicine Treatment
Experimental group (integrated traditional Chinese and Western medicine treatment group):Oral and collapsed traditional Chinese medicine and Conventional Western Medicine Treatment

Sponsors

Beijing Children's Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 18 Years

Inclusion criteria

Inclusion criteria: Meets the diagnostic criteria for Western medicine severe Mycoplasma pneumonia and traditional Chinese medicine phlegm heat closed lung syndrome, aged 5-18 years old; The family members of the affected child are fully aware of the significance of this study and are willing to cooperate with its implementation.

Exclusion criteria

Exclusion criteria: Individuals with serious complications such as toxic encephalopathy, heart failure, and respiratory failure; Patients with combined immune system, blood system, nervous system diseases, congenital genetic metabolic diseases, and tumor diseases; Individuals who are allergic to the drugs used in this study.

Design outcomes

Primary

MeasureTime frame
Efficiency;

Secondary

MeasureTime frame
Pulmonary function;Absorption of lesions in chest imaging;Time for fever relief, cough and asthma relief, and disappearance of lung rales;Liver and kidney function, CRP, LDH, IL-1 ß\ IL-6, D-dimer levels;

Countries

China

Contacts

Public ContactHaojing

Beijing Children's Hospital Affiliated to Capital Medical University

haojing115@sina.com13370115028

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026